Cbl-b inhibitors therapy(Simcere)

N/A

Report date: 2024/08/16 10:52:19
NME

Base Information

Drug NameCbl-b inhibitors therapy(Simcere)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionE3 ubiquitin-protein ligase CBL-B inhibitors
TargetsE3 ubiquitin-protein ligase CBL-B
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNanjing Simcere Dongyuan Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNanjing Simcere Dongyuan Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A